×
ADVERTISEMENT

FEBRUARY 4, 2022

EUA Recommendations Remain in Effect

ACIP Votes to Recommend Use of Spikevax in Adults 18 and Older

By Marie Rosenthal

In a unanimous decision, the Advisory Committee on Immunization Practices (ACIP) voted to recommend the Moderna COVID-19 vaccine (Spikevax) two-dose primary series for people 18 years of age and older, which the FDA approved on Jan. 31.

All other COVID-19 ACIP recommendations that address the use of COVID-19 vaccines under an emergency use authorization (EUA), such as booster or third doses for immunocompromised individuals, remain in effect.

The FDA granted full approval for